Results 301 to 310 of about 35,141 (364)

Yaf9, a Novel NuA4 Histone Acetyltransferase Subunit, Is Required for the Cellular Response to Spindle Stress in Yeast

open access: green, 2003
Ivan Le Masson   +7 more
openalex   +1 more source

UGDH Lactylation Aggravates Osteoarthritis by Suppressing Glycosaminoglycan Synthesis and Orchestrating Nucleocytoplasmic Transport to Activate MAPK Signaling

open access: yesAdvanced Science, Volume 12, Issue 20, May 29, 2025.
Lactylation of UDP‐glucose dehydrogenase (UGDH) represses its enzymatic activity and causes glycosaminoglycans loss. In addition, UGDH lactylation facilitates its interaction with chromosome region maintenance 1 (CRM1) and promotes the nucleocytoplasmic transport.
Weiren Lan   +8 more
wiley   +1 more source

Tax Recruitment of CBP/p300, via the KIX Domain, Reveals a Potent Requirement for Acetyltransferase Activity That Is Chromatin Dependent and Histone Tail Independent

open access: green, 2003
Sara A. Georges   +5 more
openalex   +1 more source

Analysis and Identification of Therapeutic Targets for Neuronal Regeneration After Ischemic Stroke

open access: yesBrain and Behavior, Volume 15, Issue 5, May 2025.
In this study, we screened and analyzed targets associated with neuronal regeneration after ischemic stroke (IS), and detected the expression of corresponding genes in cellular models. Our findings suggest that EGR1 and NR4A1 may represent promising therapeutic targets of neuronal regeneration after IS.
Xiao‐Li Min   +8 more
wiley   +1 more source

Chidamide, a Histone Deacetylase Inhibitor, Combined With R‐GemOx in Relapsed/Refractory Diffuse Large B‐Cell Lymphoma (TRUST): A Multicenter, Single‐Arm, Phase 2 Trial

open access: yesCancer Medicine, Volume 14, Issue 9, May 2025.
ABSTRACT Background Histone deacetylase (HDAC) inhibitors demonstrated a synergistic anti‐tumor effect with rituximab and chemotherapy in preclinical studies on diffuse large B‐cell lymphoma (DLBCL). This phase 2 trial aimed to evaluate the efficacy and safety of chidamide, an orally active HDAC inhibitor, plus the R‐GemOx regimen for relapsed ...
Qihua Zou   +24 more
wiley   +1 more source

Advances in the Study of Metabolic Reprogramming in Gastric Cancer

open access: yesCancer Medicine, Volume 14, Issue 10, May 2025.
ABSTRACT Background Gastric cancer is one of the most prevalent malignancies of the digestive system and is associated with a poor prognosis, particularly in advanced metastatic stages, where the 5‐year survival rate is significantly low. Methods Recent research has demonstrated that metabolic reprogramming—including alterations in glucose, lipid, and ...
Yu Rong, Yuanyin Teng, Xiaoying Zhou
wiley   +1 more source

USP22 promotes the proliferation and Sorafenib resistance of hepatocellular carcinoma cells via its deubiquitinase activity

open access: yesClinical and Translational Medicine, Volume 15, Issue 5, May 2025.
USP22 promotes the proliferation of hepatocellular carcinoma cells via deubiquitinating and stabilising cyclin‐dependent kinase CDK11B, and it inhibits Sorafenib‐induced ferroptosis by decreasing H2BK120ub occupancy at TFRC TSS downstream region. Abstract Background Hepatocellular carcinoma remains one of the most lethal cancers, characterized by poor ...
Xiaochen Wang   +8 more
wiley   +1 more source

Regulation and Function of the Atypical IκBs—Bcl‐3, IκBNS, and IκBζ—in Lymphocytes and Autoimmunity

open access: yesEuropean Journal of Immunology, Volume 55, Issue 5, May 2025.
This review article summarizes the currently available information on the functions of atypical IκB proteins including Bcl‐3, IκBNS, and IκBζ, which have been studied mostly in mouse models. We focus on the regulation of these modulators of transcription, describe their role in lymphocyte differentiation, and their involvement in the development of ...
Tanja Kübelbeck   +7 more
wiley   +1 more source

Home - About - Disclaimer - Privacy